title: Chase H&Q--18th Annual Healthcare Conference. 10-13 January 2000, San Francisco, CA, USA.
abstract: The Chase H&Q Healthcare Conference is held annually in January and provides an excellent opportunity to obtain an overall impression of the state of the pharmaceutical and biotechnology industry. Chase H&Q's flagship Healthcare and Technology conferences have become the primary checkpoints for major growth stock investors to gauge the pulse of entire industry groups as well as particular companies. The 17th Annual Healthcare Conference attracted approximately 235 companies and 3300 total attendees. This year, more than 240 companies from biotechnology, life science, medical products, healthcare service and healthcare internet industries, were presented in five parallel sessions at the 18th Annual Healthcare Conference, which was attended by over 3500 delegates. As the conference was directed primarily at analysts, there was little in the way of reporting of 'grass roots' science. This report focuses on some of the companies who have made great strides during 1999, and for whom 2000 looks set to be a challenging and exciting year.
authors.affiliation: Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1P 6LB, UK. Justine.Hookes@cursci.co.uk
authors.forename: J
authors.initials: J
authors.lastname: Hookes